Biomere is proud to welcome Kristin Sapp, M.S., CMAR as the Associate Director of the Genetically Modified Animal Program.
Kristin brings with her greater than 20 years of experience in the field. Kristin specializes in colony management, study design, and hands-on support of investigators for their individual programs. Trained as a microinjectionist, she is also proficient in the most current CARD (Center for Animal Resources and Development) methods for rederivation, cryopreservation, IVF, and strain rescue. In Kristin’s new role, her main focus will be on transgenic mouse model generation and colony management with specialized attention and guidance to drive investigator’s projects to the next level.
Please join us in giving Kristin a warm welcome!
Biomere will be exhibiting at the World Preclinical Congress in Boston from June 12-16, 2017! Come visit us at booth #209 to learn more about our capabilities or just stop by to say hi! If you would like to set up a meeting during these times, please email email@example.com with some dates and times that work for you. We look forward to seeing you there! http://www.worldpreclinicalcongress.com/
Biomere will be in Baltimore, Maryland at ARVO 2017 from May 7- 11! We are excited to be exhibiting with Ora Clinical, Inc. at booth #4206 and will have a lot of exciting information to share. Please let us know if you will be at ARVO so we can set up a time to chat! If you have any questions or would like to set up a meeting to learn more about our ocular capabilities, email firstname.lastname@example.org
Worcester, MA, May 10, 2016; Biomedical Research Models, Inc. (BRM) is excited to announce the rebranding of its Contract Research Organization (CRO) as Biomere. The shift to doing business as Biomere serves as the catalyst behind several key strategic initiatives launching what we are confident will be an important resource for the industry dedicated to research and drug discovery.
Biomere’s dedication towards providing its clients with the best, personalized service in the industry was further advanced by a plan to consolidate at a single location. In April, Biomere took the first step towards this goal by moving into a portion of its newly renovated, state-of-the-art facility. This first phase in the transition to a single site provided greater expansion of one of its fastest growing programs along with new space for scientific, general and administrative staff. The remaining portion of the facility at 57 Union Street in Worcester, MA and completion of the transition will occur this summer. “The consolidation of our existing facilities within a single site provides us with greatly enhanced operational efficiencies. In addition, the first phase of this strategy provides us with significantly expanded capabilities and capacity giving us the means to provide our sponsors with the best value for their discovery dollars”, said Dennis Guberski, President and Chairman at Biomere.
In addition and as part of the company’s overall strategy, a number of key personnel moves were announced. In March, Mark Nedelman, MS, MBA was named as CEO. Over the course of Mark’s 30 year career in the CRO and biopharmaceutical industries, he has played leading roles growing research based businesses as GM of a preclinical business unit at Charles River Labs along with heading preclinical pharmacology at Centocor contributing to the development and approval of a number of first-in-class drugs.
April Hall, MS, MBA was also named as Vice President of Business Development. A biomedical engineer by training, April has 25 years’ experience leading business development efforts at a number of leading contract labs including Charles River, Transgenomics and Sinclair Research.
“With April leading our business development efforts and Mark assuming overall leadership of the company, I am excited for Biomere and look forward to its transformation as we evolve to better meet the needs of the industry and our clients” commented Guberski.
About Biomere: Biomere or Biomedical Research Models, Inc. (BRM) is a preclinical contract research company located in Worcester, MA that offers a full range of research services to the life sciences industries.
Springfield Award Program Honors the Achievement
SPRINGFIELD September 2, 2013 – Biomedical Research Models Inc has been selected for the 2013 Best of Springfield Award in the Research Services category by the Springfield Award Program.
Each year, the Springfield Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make the Springfield area a great place to live, work and play.
Various sources of information were gathered and analyzed to choose the winners in each category. The 2013 Springfield Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the Springfield Award Program and data provided by third parties.
About Springfield Award Program
The Springfield Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the Springfield area. Recognition is given to those companies that have shown the ability to use their best practices and implemented programs to generate competitive advantages and long-term value.
The Springfield Award Program was established to recognize the best of local businesses in our community. Our organization works exclusively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Our mission is to recognize the small business community’s contributions to the U.S. economy.
Springfield Award Program
Springfield Award Program